Clinical Impact Of Ppr And The Supportive Therapies

Peste des Petits Ruminants (PPR) is one of the most severe viral diseases affecting small ruminants, especially goats, and its clinical presentation clearly reflects its destructive nature. Affected animals commonly exhibit fever(40-42°c), depression, loss of appetite, nasal and ocular discharges, ulcerative mouth lesions, foul-smelling diarrhea, labored breathing, and rapid weight loss. As the disease progresses, animals become weak, dehydrated, and prone to secondary infections, often leading to death within a short period. The absence of a specific curative treatment due to the viral nature of PPR further intensifies its impact, making outbreaks emotionally and economically devastating for livestock keepers.

PPR still remains a major concern across Africa, with East Africa bearing a particularly heavy burden. In countries such as Uganda, the disease is considered endemic and continues to pose a serious threat to small ruminant production systems. The widespread practice of communal grazing, frequent livestock movements, informal cross-border trade, and live animal markets greatly facilitate transmission. In Uganda, porous borders and mixed farming systems increase contact between infected and susceptible animals, allowing the virus to circulate persistently, especially among goats, which are highly susceptible.

Despite to the challenge, local governments—through district production departments —have played a central role in PPR control efforts, supported by valuable contributions from the private sector. These efforts include coordinated vaccination campaigns, farmer sensitization programs, disease surveillance, animal movement control permits and timely outbreak reporting. Private veterinary drug suppliers, animal health practitioners, and development partners have complemented government actions by ensuring access to vaccines, veterinary inputs, and technical support. This collaboration has strengthened frontline disease response, improved farmer compliance, and enhanced overall animal health service delivery at the community level.

At a farm local level, supportive treatment remains essential in managing PPR cases and reducing losses. Meloxicash (meloxicam), a non-steroidal anti-inflammatory drug, has widely proven the ability to control fever, pain, and swelling effortlessly. This improves comfort of affected animals to withstand the disease. This can be complimented by Ashienro injection; it is another magical antibiotic. It suppresses opportunistic secondary bacterial infections. It is important to note, that even though these drugs don’t cure, but at least their timely use significantly limits the risks of other complications and losses therefore front lining them as a first choice can be of ideal significance.

By Miss Faridah

NamuwongeTechnical Sales representative (ALS)